Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
parasitic intestinal diseases
MeSH D007411 - parasitic intestinal diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D007410:
Intestinal diseases
0 Companies
0 Drugs
Success rate
D010272:
Parasitic diseases
0 Companies
0 Drugs
Success rate
D007411:
Parasitic intestinal diseases
2 Companies
1 Drug
$
Success rate
D001447:
Balantidiasis
0 Companies
0 Drugs
Success rate
D003457:
Cryptosporidiosis
7 Companies
2 Drugs
$
Success rate
D004030:
Dientamoebiasis
0 Companies
0 Drugs
Success rate
D004404:
Amebic dysentery
0 Companies
0 Drugs
Success rate
D005873:
Giardiasis
56 Companies
7 Drugs
$
Success rate
D016776:
Blastocystis infections
0 Companies
0 Drugs
Success rate
D017129:
Anisakiasis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
1/1
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bayer
Praziquantel
,
Praziquantel, (r)-
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use